Covid-19 Impact on Global Influenza Vaccine Market Size, Status and Forecast 2020-2026

Covid-19 Impact on Global Influenza Vaccine Market Size, Status and Forecast 2020-2026

Table of Contents
1 Study Coverage
1.1 Influenza Vaccine Product Introduction
1.2 Market Segments
1.3 Key Influenza Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Influenza Vaccine Market Size Growth Rate by Type
1.4.2 Whole Virus Vaccines
1.4.3 Split Virus Vaccines
1.4.4 Subunit Vaccines
1.4.5 Live Attenuated Virus Vaccines
1.5 Market by Application
1.5.1 Global Influenza Vaccine Market Size Growth Rate by Application
1.5.2 For Children (6 months to 3 years)
1.5.3 For Adults and Children over 3 years
1.6 Coronavirus Disease 2019 (Covid-19): Influenza Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Influenza Vaccine Industry
1.6.1.1 Influenza Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Influenza Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Influenza Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Influenza Vaccine Market Size Estimates and Forecasts
2.1.1 Global Influenza Vaccine Revenue 2015-2026
2.1.2 Global Influenza Vaccine Sales 2015-2026
2.2 Influenza Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Influenza Vaccine Competitor Landscape by Players
3.1 Influenza Vaccine Sales by Manufacturers
3.1.1 Influenza Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Influenza Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Influenza Vaccine Revenue by Manufacturers
3.2.1 Influenza Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Influenza Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Influenza Vaccine Revenue in 2019
3.2.5 Global Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Influenza Vaccine Price by Manufacturers
3.4 Influenza Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Influenza Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Influenza Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Influenza Vaccine Market Size by Type (2015-2020)
4.1.1 Global Influenza Vaccine Sales by Type (2015-2020)
4.1.2 Global Influenza Vaccine Revenue by Type (2015-2020)
4.1.3 Influenza Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Influenza Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Influenza Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Influenza Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Influenza Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Influenza Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Influenza Vaccine Market Size by Application (2015-2020)
5.1.1 Global Influenza Vaccine Sales by Application (2015-2020)
5.1.2 Global Influenza Vaccine Revenue by Application (2015-2020)
5.1.3 Influenza Vaccine Price by Application (2015-2020)
5.2 Influenza Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Influenza Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Influenza Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Influenza Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Influenza Vaccine by Country
6.1.1 North America Influenza Vaccine Sales by Country
6.1.2 North America Influenza Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Influenza Vaccine Market Facts & Figures by Type
6.3 North America Influenza Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Influenza Vaccine by Country
7.1.1 Europe Influenza Vaccine Sales by Country
7.1.2 Europe Influenza Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Influenza Vaccine Market Facts & Figures by Type
7.3 Europe Influenza Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Influenza Vaccine by Region
8.1.1 Asia Pacific Influenza Vaccine Sales by Region
8.1.2 Asia Pacific Influenza Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Influenza Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Influenza Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Influenza Vaccine by Country
9.1.1 Latin America Influenza Vaccine Sales by Country
9.1.2 Latin America Influenza Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Influenza Vaccine Market Facts & Figures by Type
9.3 Central & South America Influenza Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Influenza Vaccine by Country
10.1.1 Middle East and Africa Influenza Vaccine Sales by Country
10.1.2 Middle East and Africa Influenza Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Influenza Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Influenza Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 CSL
11.1.1 CSL Corporation Information
11.1.2 CSL Description, Business Overview and Total Revenue
11.1.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.1.4 CSL Influenza Vaccine Products Offered
11.1.5 CSL Recent Development
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Description, Business Overview and Total Revenue
11.2.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GSK Influenza Vaccine Products Offered
11.2.5 GSK Recent Development
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Corporation Information
11.3.2 Sanofi Pasteur Description, Business Overview and Total Revenue
11.3.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi Pasteur Influenza Vaccine Products Offered
11.3.5 Sanofi Pasteur Recent Development
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Description, Business Overview and Total Revenue
11.4.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Mylan Influenza Vaccine Products Offered
11.4.5 Mylan Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Description, Business Overview and Total Revenue
11.5.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AstraZeneca Influenza Vaccine Products Offered
11.5.5 AstraZeneca Recent Development
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Description, Business Overview and Total Revenue
11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer Influenza Vaccine Products Offered
11.6.5 Pfizer Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Corporation Information
11.7.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.7.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Johnson & Johnson Influenza Vaccine Products Offered
11.7.5 Johnson & Johnson Recent Development
11.1 CSL
11.1.1 CSL Corporation Information
11.1.2 CSL Description, Business Overview and Total Revenue
11.1.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.1.4 CSL Influenza Vaccine Products Offered
11.1.5 CSL Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Influenza Vaccine Market Estimates and Projections by Region
12.1.1 Global Influenza Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Influenza Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Influenza Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Influenza Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Influenza Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Influenza Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Influenza Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Influenza Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Influenza Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Influenza Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Influenza Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Influenza Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Influenza Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Influenza Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Influenza Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Influenza Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Influenza Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Influenza Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Influenza Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Influenza Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Influenza Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Influenza Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Influenza Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Influenza Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Influenza Vaccine Market Segments
Table 2. Ranking of Global Top Influenza Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Influenza Vaccine Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Whole Virus Vaccines
Table 5. Major Manufacturers of Split Virus Vaccines
Table 6. Major Manufacturers of Subunit Vaccines
Table 7. Major Manufacturers of Live Attenuated Virus Vaccines
Table 8. COVID-19 Impact Global Market: (Four Influenza Vaccine Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Influenza Vaccine Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Influenza Vaccine Players to Combat Covid-19 Impact
Table 13. Global Influenza Vaccine Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 14. Global Influenza Vaccine Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 15. Global Influenza Vaccine Sales by Regions 2015-2020 (K Doses)
Table 16. Global Influenza Vaccine Sales Market Share by Regions (2015-2020)
Table 17. Global Influenza Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Influenza Vaccine Sales by Manufacturers (2015-2020) (K Doses)
Table 19. Global Influenza Vaccine Sales Share by Manufacturers (2015-2020)
Table 20. Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Vaccine as of 2019)
Table 22. Influenza Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Influenza Vaccine Price (2015-2020) (USD/Doses)
Table 25. Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Influenza Vaccine Product Type
Table 27. Date of International Manufacturers Enter into Influenza Vaccine Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 30. Global Influenza Vaccine Sales Share by Type (2015-2020)
Table 31. Global Influenza Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Influenza Vaccine Revenue Share by Type (2015-2020)
Table 33. Influenza Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Doses)
Table 34. Global Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 35. Global Influenza Vaccine Sales Share by Application (2015-2020)
Table 36. North America Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 37. North America Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 38. North America Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 40. North America Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 41. North America Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 42. North America Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 43. North America Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 44. Europe Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 45. Europe Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 46. Europe Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 48. Europe Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 49. Europe Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 50. Europe Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 51. Europe Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Influenza Vaccine Sales by Region (2015-2020) (K Doses)
Table 53. Asia Pacific Influenza Vaccine Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Influenza Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Influenza Vaccine Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 57. Asia Pacific Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 59. Asia Pacific Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 60. Latin America Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 61. Latin America Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 64. Latin America Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 65. Latin America Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 66. Latin America Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 67. Latin America Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 69. Middle East and Africa Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 73. Middle East and Africa Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 75. Middle East and Africa Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 76. CSL Corporation Information
Table 77. CSL Description and Major Businesses
Table 78. CSL Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 79. CSL Product
Table 80. CSL Recent Development
Table 81. GSK Corporation Information
Table 82. GSK Description and Major Businesses
Table 83. GSK Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 84. GSK Product
Table 85. GSK Recent Development
Table 86. Sanofi Pasteur Corporation Information
Table 87. Sanofi Pasteur Description and Major Businesses
Table 88. Sanofi Pasteur Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 89. Sanofi Pasteur Product
Table 90. Sanofi Pasteur Recent Development
Table 91. Mylan Corporation Information
Table 92. Mylan Description and Major Businesses
Table 93. Mylan Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 94. Mylan Product
Table 95. Mylan Recent Development
Table 96. AstraZeneca Corporation Information
Table 97. AstraZeneca Description and Major Businesses
Table 98. AstraZeneca Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 99. AstraZeneca Product
Table 100. AstraZeneca Recent Development
Table 101. Pfizer Corporation Information
Table 102. Pfizer Description and Major Businesses
Table 103. Pfizer Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 104. Pfizer Product
Table 105. Pfizer Recent Development
Table 106. Johnson & Johnson Corporation Information
Table 107. Johnson & Johnson Description and Major Businesses
Table 108. Johnson & Johnson Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 109. Johnson & Johnson Product
Table 110. Johnson & Johnson Recent Development
Table 111. Global Influenza Vaccine Sales Forecast by Regions (2021-2026) (K Doses)
Table 112. Global Influenza Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 113. Global Influenza Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 114. Global Influenza Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 115. North America: Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 116. North America: Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Europe: Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 118. Europe: Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Asia Pacific: Influenza Vaccine Sales Forecast by Region (2021-2026) (K Doses)
Table 120. Asia Pacific: Influenza Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 121. Latin America: Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 122. Latin America: Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Middle East and Africa: Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 124. Middle East and Africa: Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 126. Key Challenges
Table 127. Market Risks
Table 128. Main Points Interviewed from Key Influenza Vaccine Players
Table 129. Influenza Vaccine Customers List
Table 130. Influenza Vaccine Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Vaccine Product Picture
Figure 2. Global Influenza Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Whole Virus Vaccines Product Picture
Figure 4. Split Virus Vaccines Product Picture
Figure 5. Subunit Vaccines Product Picture
Figure 6. Live Attenuated Virus Vaccines Product Picture
Figure 7. Global Influenza Vaccine Sales Market Share by Application in 2020 & 2026
Figure 8. For Children (6 months to 3 years)
Figure 9. For Adults and Children over 3 years
Figure 10. Influenza Vaccine Report Years Considered
Figure 11. Global Influenza Vaccine Market Size 2015-2026 (US$ Million)
Figure 12. Global Influenza Vaccine Sales 2015-2026 (K Doses)
Figure 13. Global Influenza Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Influenza Vaccine Sales Market Share by Region (2015-2020)
Figure 15. Global Influenza Vaccine Sales Market Share by Region in 2019
Figure 16. Global Influenza Vaccine Revenue Market Share by Region (2015-2020)
Figure 17. Global Influenza Vaccine Revenue Market Share by Region in 2019
Figure 18. Global Influenza Vaccine Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Influenza Vaccine Revenue in 2019
Figure 20. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Influenza Vaccine Sales Market Share by Type (2015-2020)
Figure 22. Global Influenza Vaccine Sales Market Share by Type in 2019
Figure 23. Global Influenza Vaccine Revenue Market Share by Type (2015-2020)
Figure 24. Global Influenza Vaccine Revenue Market Share by Type in 2019
Figure 25. Global Influenza Vaccine Market Share by Price Range (2015-2020)
Figure 26. Global Influenza Vaccine Sales Market Share by Application (2015-2020)
Figure 27. Global Influenza Vaccine Sales Market Share by Application in 2019
Figure 28. Global Influenza Vaccine Revenue Market Share by Application (2015-2020)
Figure 29. Global Influenza Vaccine Revenue Market Share by Application in 2019
Figure 30. North America Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 31. North America Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Influenza Vaccine Sales Market Share by Country in 2019
Figure 33. North America Influenza Vaccine Revenue Market Share by Country in 2019
Figure 34. U.S. Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 35. U.S. Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 37. Canada Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Influenza Vaccine Market Share by Type in 2019
Figure 39. North America Influenza Vaccine Market Share by Application in 2019
Figure 40. Europe Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 41. Europe Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Influenza Vaccine Sales Market Share by Country in 2019
Figure 43. Europe Influenza Vaccine Revenue Market Share by Country in 2019
Figure 44. Germany Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 45. Germany Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 47. France Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 49. U.K. Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Italy Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 53. Russia Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Influenza Vaccine Market Share by Type in 2019
Figure 55. Europe Influenza Vaccine Market Share by Application in 2019
Figure 56. Asia Pacific Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 57. Asia Pacific Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Influenza Vaccine Sales Market Share by Region in 2019
Figure 59. Asia Pacific Influenza Vaccine Revenue Market Share by Region in 2019
Figure 60. China Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 61. China Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 63. Japan Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 65. South Korea Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 67. India Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Australia Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Taiwan Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Indonesia Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Thailand Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Malaysia Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Philippines Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 81. Vietnam Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Influenza Vaccine Market Share by Type in 2019
Figure 83. Asia Pacific Influenza Vaccine Market Share by Application in 2019
Figure 84. Latin America Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 85. Latin America Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Influenza Vaccine Sales Market Share by Country in 2019
Figure 87. Latin America Influenza Vaccine Revenue Market Share by Country in 2019
Figure 88. Mexico Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 89. Mexico Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Brazil Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 93. Argentina Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Influenza Vaccine Market Share by Type in 2019
Figure 95. Latin America Influenza Vaccine Market Share by Application in 2019
Figure 96. Middle East and Africa Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 97. Middle East and Africa Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Influenza Vaccine Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Influenza Vaccine Revenue Market Share by Country in 2019
Figure 100. Turkey Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Turkey Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 103. Saudi Arabia Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. UAE Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 105. UAE Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Influenza Vaccine Market Share by Type in 2019
Figure 107. Middle East and Africa Influenza Vaccine Market Share by Application in 2019
Figure 108. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. North America Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 116. North America Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Europe Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 118. Europe Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Asia Pacific Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 120. Asia Pacific Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Latin America Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 122. Latin America Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Middle East and Africa Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 124. Middle East and Africa Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Porter's Five Forces Analysis
Figure 126. Channels of Distribution
Figure 127. Distributors Profiles
Figure 128. Bottom-up and Top-down Approaches for This Report
Figure 129. Data Triangulation
Figure 130. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs